Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis

Published:2020-11 Issue:5 Volume:125 Page:589-596.e3
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Du Kun,Qing Hui,Zheng Ming,Wang Xiangdong,Zhang Luo

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference43 articles.

1. A survey of the burden of allergic rhinitis in Europe;Canonica;Allergy,2007

2. A survey of the burden of allergic rhinitis in the USA;Schatz;Allergy,2007

3. Increasing prevalence of allergic rhinitis in China;Zhang;Allergy Asthma Immunol Res,2019

4. Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma;Li;J Thorac Dis,2019

5. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011;Wang;Allergy,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focused allergic rhinitis practice parameter for Canada;Allergy, Asthma & Clinical Immunology;2024-08-08

2. A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis;Current Pharmaceutical Design;2024-04

3. Modern approaches to rational combination pharmacotherapy of allergic rhinitis;Russian Bulletin of Otorhinolaryngology;2024

4. Intranasal Morphology Transformation Nanomedicines for Long-Term Intervention of Allergic Rhinitis;ACS Nano;2023-12-13

5. The IL‐31/CysLT2R axis is associated with itching in patients with allergic rhinitis;International Forum of Allergy & Rhinology;2023-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3